There was a fair bit of news coverage recently regarding the recent sale of a large block of Biovail shares. Biovail’s largest shareholder, founder and previous CEO Eugene Melnyk took his stake in the company down by 9.6 million shares to only 232,000 shares worth close to 4 million C$. At the peak, Mr. Melnyk held 25%...
Read more »
Zarlink semiconductor (Zarlink, ZL on the TSX, ZARLF on the OTC BB in the US) has been getting a lot of positive press lately. Just in the last few weeks fund managers Robert Floyd of R.A.Floyd Capital and Bob McWhirter of Selective Asset Management...
Read more »
Last week, on March 12th, the Canadian dollar closed for the first time over the 98 cent level. Adding to the significance of this event is that it is the first weekly close over the key 97.5 level since July/August 2008. This important, albeit potential, breakout is...
Read more »
In a previous note, we highlighted the iShares DJ Pharma E.T.F. (IHE) as a possible way to gain exposure the large pharmaceauticals in the US. In this note, we discuss Merck and company (MRK on...
Read more »
There are very few large health care companies in Canada. In the large cap S&P/TSX 60 Index (XIU), there is only .24% in the index corresponding to the weighting...
Read more »
Seasonality is a very important aspect of the way markets have worked for many years. One of the books that documents market behaviour throughout the calendar year is the...
Read more »
